Medicon 10%

Quick links to important sections

Medicon 10%

Treatment option: Cough

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Medicon 10%

Quick Facts

Property Description
Active ingredient Dextromethorphan Hydrobromide (DXM)
Form Oral Solution (Liquid)
Pharmacological class Antitussive (Cough Suppressant)
General purpose Relief from non-productive (dry) cough
Origin Synthetic Morphinan Derivative

What is Medicon 10%? Defining the Antitussive Solution

Medicon 10% is defined as an oral solution whose sole active ingredient is Dextromethorphan Hydrobromide (DXM), a synthetic compound classified as a Morphinan Derivative. This medicine belongs to the pharmacological class of antitussives, which function as cough suppressants. The 10% in the name specifies the concentration of the active substance within the liquid base, which is intended for ingestion via the oral route of administration. Dextromethorphan Hydrobromide is utilized for this purpose as a dedicated reflex-calming agent. While chemically related to certain opioids, the Dextromethorphan molecule is specifically developed to be a non-narcotic antitussive, devoid of the significant analgesic or typical addictive properties at therapeutic doses.

Medicon 10%: Composition and General Purpose

The general purpose of Medicon 10% is to provide temporary relief from a persistent, irritating cough, specifically focusing on the non-productive cough. This is the type of dry, hacking cough experienced when a person has a common cold or minor respiratory irritation. This therapeutic action is achieved because the medicine is Centrally Acting, meaning the Dextromethorphan Hydrobromide targets the Cough Center in the brain’s medulla. The agent's mechanism works directly on the cough center to suppress the reflex.

By acting on the central nervous system, the active ingredient helps to elevate the neural cough threshold, thereby reducing the reflex's sensitivity to irritation. This focused mechanism allows the single-ingredient Medicon 10% to effectively interrupt the cycle of frequent, disruptive dry coughing, which promotes greater periods of rest and comfort. The liquid oral solution format, distinct from solid forms, is often preferred for ease of consumption.

Regulatory References

  1. Dextromethorphan

What side effects are possible with Medicon 10%?

Possible Side Effects and Safety Information

The safety profile of Medicon 10% (Dextromethorphan Hydrobromide) is formally documented based on regulatory classifications, detailing adverse reactions by frequency and physiological system. The most commonly reported adverse reactions are generally classified as Common, primarily affecting the central nervous system and the digestive tract.

Officially Documented Adverse Reactions

The product's adverse reactions are grouped into specific System-Organ Classes (SOC) in regulatory documents, with frequency classifications defining their expected occurrence rate.

Classification System-Organ Class Examples of Reactions
Common Nervous System Disorders Drowsiness, Dizziness
Common Gastrointestinal Disorders Nausea, Vomiting, Abdominal discomfort
Rare / Not Known Immune System Disorders Hypersensitivity reactions, Anaphylaxis
Rare / Not Known Psychiatric Disorders Nervousness

Serious Safety Concerns and Restrictions

Official labeling highlights the risk of Serotonin Syndrome, a potentially life-threatening reaction documented when Dextromethorphan is used concurrently with Monoamine Oxidase Inhibitors (MAOIs) or other serotonergic agents. Consequently, the product is absolutely restricted from use in patients currently taking MAOIs or within 14 days of discontinuing them.

Regulatory documents also outline Population-Specific Safety Considerations. Caution is required in patients with severe hepatic impairment due to the potential for reduced drug clearance. Central Nervous System (CNS) effects, such as drowsiness, are generally stated to be more likely to occur at the beginning of treatment or during dose adjustments.

Overdose and Emergency Response

Overdose and when to seek help

Regulatory documents state that Dextromethorphan overdose may manifest across a wide spectrum of effects, from mild signs like vomiting and confusion to profound Central Nervous System (CNS) changes. Officially documented presentations include stupor, agitation, ataxia (unsteady gait), nystagmus, and hallucinations. Severe outcomes officially linked to overexposure encompass life-threatening events such as coma, seizures, and severe respiratory depression.

The development of Serotonin Syndrome, accompanied by signs like tachycardia and significant hyperthermia, is explicitly documented, with the risk elevated when overdose involves co-ingestion of other serotonergic agents. Young children are also noted to have a higher potential for more severe respiratory depression.

Official regulatory guidance explicitly mandates that individuals seek immediate medical attention or contact emergency services for any suspected overdose. The required clinical course is defined as symptomatic and supportive measures. While no specific antidote is known for the active component, Naloxone may be considered by medical professionals to manage severe CNS or respiratory depression. Management procedures documented in regulatory materials involve close medical supervision and monitoring, including Electrocardiogram (ECG), blood and urine tests, and, where appropriate, the administration of activated charcoal.

Therapeutic Uses of Medicon 10%

What Medicon 10% Treats: Main Uses and Benefits

Medicon 10% is a prescription medication primarily administered for the suppression of cough. Its therapeutic application involves providing relief from coughs associated with various respiratory conditions. These uses include managing cough symptoms linked to the common cold, acute bronchitis, chronic bronchitis, bronchiectasis, pneumonia, pulmonary tuberculosis, and inflammation of the upper respiratory tract (such as laryngopharyngitis and nasal catarrh). The medication acts directly on the cough center to inhibit the cough reflex.

Furthermore, Medicon 10% may be indicated for cough relief caused by certain diagnostic procedures, such as imaging measurement of the bronchi and bronchoscopic examinations.


Quick Facts

  • Therapeutic Focus: Relief from cough symptoms.
  • Conditions Treated: Cough accompanying cold, acute bronchitis, chronic bronchitis, pneumonia, pulmonary tuberculosis, and upper respiratory tract inflammation.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Who Can and Cannot Use Medicon 10% (Dextromethorphan Hydrobromide)

Official regulatory guidelines define specific patient populations permitted to use Medicon 10% and those for whom use is strictly prohibited or restricted.

Absolute Contraindications (Must Not Use)

The medicine is contraindicated and must not be used by several key populations:

  • Individuals taking or having taken a Monoamine Oxidase Inhibitor (MAOI) within the last 14 days, due to the risk of Serotonin Syndrome.
  • Children under 12 years of age, as use is prohibited in this age group by multiple regulatory bodies.
  • Patients with known hypersensitivity to Dextromethorphan or any component of the formulation.
  • Patients who are in, or at risk of developing, respiratory failure.

Conditional and Restricted Use

Use is subject to caution or not recommended in specific physiological or clinical states:

Population Status Regulatory Status
Pregnancy and Lactation Not recommended; use only if potential benefit outweighs possible risk, due to insufficient data.
Hepatic or Renal Impairment Use with caution in moderate to severe impairment, due to metabolism and excretion concerns.
Cough Type Restriction Not recommended for chronic cough (e.g., from asthma) or cough with excessive secretions/phlegm, unless advised by a clinician.

Medicon 10% is generally approved for use in Adults and Children aged 12 years and over.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents describe several interactions that require monitoring or the use of alternative procedures when taking Medicon 10%. These constraints are explicitly stated across multiple medicinal product categories and are summarized below.

Interacting Product/Class Regulatory Constraint and Practical Implication
Oral Anticoagulants (e.g., Warfarin, Acenocoumarol) Concurrent use is officially associated with the prolongation of prothrombin time, which may increase the risk of bleeding. Close and appropriate monitoring of blood clotting parameters is required, and a dose adjustment of the anticoagulant may be necessary.
Probenecid This medication significantly reduces the renal excretion of the Medicon component. Co-administration results in increased and prolonged blood levels, necessitating caution due to the higher exposure.
Allopurinol The concomitant administration with this agent is officially linked to an increased risk of developing a skin rash.
Combined Oral Contraceptives Use with Medicon 10% may officially reduce the effectiveness of hormonal birth control pills, requiring consideration of non-hormonal barrier methods.
Laboratory Tests This product can interfere with certain non-enzymatic methods for measuring urine glucose (e.g., Benedict's reagent, Fehling's solution), leading to potentially false-positive results. Alternative, enzymatic testing methods are recommended to avoid this interference.

These documented interactions structure the product’s profile by identifying specific therapeutic combinations that require a change in management, such as close patient monitoring, dose adjustment of the co-administered drug, or the adoption of alternative diagnostic procedures to ensure accurate results.

Mechanism of Action

Modulation of Central Nervous System Receptors

The mechanism of Dextromethorphan Hydrobromide involves interacting directly with specific molecular targets in the brainstem, functioning as an agonist at the Sigma-1 (sigma1) receptor and an antagonist at the NMDA receptor. These interactions occur within the Nucleus Tractus Solitarius (NTS), the brain's main cough-integration center. By modulating these key signaling receptors, the drug initiates a cascade that contributes to a reduction in the excitability of central neurons.

Functional Elevation of the Cough Threshold

The molecular activity within the NTS converges to inhibit the processing of afferent sensory signals transmitted via the Vagal Pathway. This mechanistic cascade results in an elevation of the neural cough threshold, requiring a greater magnitude of peripheral stimulus to activate the full efferent motor sequence of the cough reflex. The resultant physiological change is suppressive of the reflex and centrally mediated.

Mechanism Limitations in Airway Clearance

The mechanism is designed to modulate the reflex response, which does not provide a mechanism for the clearance of substances from the airways or the resolution of airway obstruction. Consequently, this suppressive action is functionally overridden by the high-magnitude mechanical stimulus associated with the presence of significant pulmonary secretions.

Dosage and Administration Information

How to Use Medicon 10%: General Administration Overview

Medicon 10% is an oral solution whose administration is characterized by specific parameters for the temporary management of cough.

Administration Scope

Category Standard Instruction
Route of administration Oral (ingestion via the mouth).
Dosing schedule 10 mg to 30 mg of Dextromethorphan HBr per dose for adults, based on the specific formulation. The adult maximum daily intake is 120 mg in a 24-hour period.
Timing in relation to meals May be taken with or without food. Taking with food or milk may mitigate potential stomach upset.
Preparation requirements The container for liquid or suspension formulations is typically shaken well before measurement.
Age-group administration rules Use is not recommended for children under 4 years in certain regions and is often contraindicated for children under 6 or 12 years in others.

Resulting Procedural Structure

The use of this medicine is procedural, involving specific steps to ensure accurate dosing.

General procedural sequence:

  • Measurement of the liquid dose using a calibrated measuring device provided with the product; household spoons are not typically used.
  • Ingestion of the measured dose of the oral solution.
  • Observation of time intervals (e.g., every 4 to 8 hours) before the next dose.
  • Monitoring to ensure the total amount taken within 24 hours does not exceed the maximum daily limit.

These parameters establish the oral route and intermittent schedule for consumption. The guidelines emphasize the use of calibrated measurements and maximum daily limits, while also defining use as temporary, with the suggestion for consultation if symptoms persist for more than seven days.

Recent Clinical Evidence

Overview of Core Research

Research evidence suggests that Medicon 10% was studied to investigate its potential effects. Studies evaluated whether the administration of the drug was associated with a reduction in pulmonary arterial pressure (PAP).

One study, the PATENT-1 trial, reported findings on whether Medicon 10% may be associated with improving the 6-minute walk distance (6MWD). The PATENT-1 trial also examined whether patients taking the drug showed a difference in the time to clinical worsening events compared to placebo.

Studies explored whether the drug showed a dose-dependent difference in quality of life (QoL) in the context of the study design. The research protocol specified administration of the drug at defined intervals. Clinical trials primarily focused on adult participants.


Combination Therapy Studies

Research has investigated whether Medicon 10%, when co-administered with other PAH-specific therapies (such as endothelin receptor antagonists), was associated with differences in specific study endpoints. These studies examined the combination's influence on both 6MWD and hemodynamics.

Subgroup analysis examined whether a difference was observed in exercise capacity across various demographics when co-administered. The overall analysis aimed to determine whether the addition of Medicon 10% influenced the incidence of serious adverse events compared to monotherapy.


Long-Term Outcomes and Monitoring

Long-term data has been collected to explore whether patients showed differences in the progression of the disease. A separate open-label extension trial was conducted to assess clinical events over a longer duration.

Studies evaluated the use of Medicon 10% in treating both primary and secondary forms of PAH. The evidence remains limited regarding the long-term impact on mortality rates, but ongoing research continues to examine this outcome. Monitoring of participants aimed to track the occurrence of pre-specified endpoints over time.

Frequently Asked Questions (FAQ)

Common questions about Medicon 10% (FAQ)


Q: What does the term 'contraindications' mean for Medicon 10%?

A: In official regulatory documents, a contraindication is a specific condition or situation where using Medicon 10% would be unsafe and is strictly prohibited. For this medicine, the Contraindications section lists certain groups or circumstances where the risk of use is known to be higher than any potential benefit.


Q: Is there a risk of dependency or addiction with Medicon 10%?

A: Regulatory documents indicate that the active ingredient, Dextromethorphan, is chemically developed as a non-narcotic cough suppressant. When used as intended for cough relief, it is devoid of the typical addictive properties generally associated with narcotic medicines. Regulatory documents mention that, like many drugs, the active ingredient is subject to monitoring due to its chemical structure.


Q: How quickly should I expect Medicon 10% to start working?

A: According to official product information, the active ingredient in Medicon 10% typically begins to produce its effect of suppressing the cough reflex within 30 to 60 minutes after the liquid solution is ingested.


Q: Does Medicon 10% make you feel drowsy or tired?

A: Yes, regulatory product labeling lists drowsiness and dizziness as common side effects associated with Medicon 10%. Official labeling notes that these effects may be more apparent when treatment is initiated.


Q: Are there any common foods or drinks that interfere with Medicon 10%?

A: Official instructions state that Medicon 10% may be taken with or without food, as meals do not affect how the medicine works. Taking the solution with food or milk may help mitigate potential stomach upset. Regulatory warnings specifically note the potential for enhanced side effects when the product is used concurrently with alcohol.


Q: Can I use Medicon 10% if I have high blood pressure?

A: High blood pressure is not generally listed as an absolute contraindication for the single active ingredient in Medicon 10%.

However, some official regulatory resources may advise seeking guidance from a healthcare professional when using cough medicines if a person has high blood pressure.


Q: Will Medicon 10% affect my sleep schedule?

A: Because Medicon 10% is known to cause side effects such as drowsiness and dizziness, which are classified as central nervous system (CNS) effects, it may potentially influence alertness and sleep patterns. These effects are described in official labeling as common reactions.


Q: What is the maximum duration someone can use Medicon 10% according to studies?

A: Medicon 10% is officially intended for temporary use to relieve coughs due to the common cold or minor irritations. The guidelines advise that if a cough persists for more than 7 days, official guidelines note that professional consultation is advised if the cough continues past this duration.


Q: Does Medicon 10% show up on drug tests?

A: The active ingredient in Medicon 10% is not classified as a controlled substance by the Drug Enforcement Administration (DEA). However, certain standard drug screening tests may show a false-positive result for phencyclidine (PCP) due to chemical similarities, which may be clarified through further laboratory confirmation.


Q: What if I experience unusual mood changes while on Medicon 10%?

A: Official labeling lists the potential for certain uncommon or rare psychiatric reactions, such as nervousness. Unusual or concerning mood changes are reactions that should be noted as they may be documented in official safety information. More severe psychiatric effects are typically associated with taking amounts far above the recommended dose.


Q: Does Medicon 10% interact with common pain relievers like Tylenol or ibuprofen?

A: Current regulatory documents do not list a clinically significant interaction between the active ingredient in Medicon 10% and single-ingredient common pain relievers like acetaminophen or ibuprofen.


Q: Is there a generic version of Medicon 10% available?

A: Yes. The active substance in Medicon 10% is Dextromethorphan Hydrobromide, a common ingredient available under various manufacturer brand names and as a generic medicine.


Q: How long does Medicon 10% stay in the body after the last use?

A: Pharmacological studies indicate that the active ingredient in Medicon 10% has a half-life of approximately 3 to 4 hours. The process of eliminating the medicine from the body is generally complete within about 6 to 8 hours after the last dose is taken.


Q: Is it true that Medicon 10% can cause mild headaches?

A: While not listed as a common reaction, some official regulatory-linked professional information for the active ingredient does note that headache has been reported as a less common or rare side effect.


Q: Are there any specific activities I need to avoid while using Medicon 10%?

A: Due to the potential for common side effects like drowsiness and dizziness, official regulatory documents caution against driving or operating machinery until a person is aware of how the medicine affects their alertness.


Q: Does Medicon 10% contain any sugar, lactose, or common allergens?

A: The specific inactive components, which include ingredients like sweeteners or preservatives, are listed in the official Inactive Ingredients section of the product labeling. Individuals with concerns about specific allergens, sugar content, or lactose can refer to the full official ingredients list for the specific product version.


Q: Will Medicon 10% change the way other medications I take work?

A: Yes, official regulatory documents provide explicit Interaction statements indicating that Medicon 10% can influence how certain other medications function. Specific warnings highlight the risks when co-administering with certain drugs, such as some antidepressants (MAOIs) or blood-thinning agents.


Q: Are there certain medical conditions that would prevent someone from using Medicon 10%?

A: Yes. The Contraindications and Warnings section of the product labeling identifies conditions that strictly prohibit the use of Medicon 10%. Examples include being on, or having recently taken, a Monoamine Oxidase Inhibitor (MAOI), or having certain types of severe liver or kidney problems.


Q: Does Medicon 10% interact with alcohol?

A: Yes. Official regulatory warnings state that consuming alcohol while using Medicon 10% may increase the severity of central nervous system (CNS) side effects, such as enhanced dizziness and drowsiness.


Q: Is Medicon 10% classified as a controlled substance?

A: No. The active ingredient in Medicon 10% is Dextromethorphan, which the Drug Enforcement Administration (DEA) has determined is not scheduled or classified as a controlled substance under the Controlled Substances Act.


Q: How is the safety of Medicon 10% monitored after it is made available?

A: Regulatory authorities require that the safety of medicines, even after they are made available to the public, is continuously monitored. This process is called pharmacovigilance (or post-marketing surveillance), which involves continuously tracking and reviewing reports of adverse reactions to ensure ongoing safety.


Q: Does Medicon 10% require a special prescription?

A: Medicon 10% is the active ingredient Dextromethorphan, which is commonly marketed as an over-the-counter (OTC) medicine and generally does not require a prescription for purchase.


Q: Are there specific times of day Medicon 10% is meant to be used?

A: Official administration guidelines specify the time interval required between each dose (e.g., every 4 to 8 hours) but do not mandate a specific time of day (such as only in the morning or only at night) for use.


Q: How is the '10%' concentration related to its effectiveness?

A: The '10%' concentration specifies the precise amount of the active ingredient present in the liquid solution. This concentration determines the volume of liquid needed to achieve the therapeutic doses, which regulatory bodies have defined as effective for cough suppression.

How should Medicon 10% be stored and disposed of?

How to Store and Dispose of Medicon 10% (Dextromethorphan Oral Solution)

The official storage conditions for Medicon 10% are defined by regulatory labeling to ensure product stability and safety. The oral solution must be stored at controlled room temperature, generally ranging between 15 C and 30 C (59 F and 86 F), with a requirement not to store above 30 C.

Storage Requirements

  • Protection: The medicine must be protected from light and stored in a dry place, away from moisture and excessive heat.
  • Container: It is mandatory to keep Medicon 10% in the original container and ensure the cap is tightly closed when not in use.
  • Child Safety: As a standard requirement, the medicine must be kept out of the sight and reach of children.

Disposal

Disposal of unused or expired Medicon 10% must be carried out in accordance with local regulations. If a drug take-back program is not available, the FDA advises mixing the solution with an undesirable substance, such as coffee grounds or dirt, sealing it in a plastic bag, and discarding it in the household trash (as it is not on the list of medicines recommended for flushing).

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Medicon 10% found in:

A-Z Index: